We are live on
!
Find out more
Eterna Therapeutics
ERNA
ERNA
3 hedge funds and large institutions have $2.18M invested in Eterna Therapeutics in 2013 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
+3
Holders Change %
–
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
EAM
1
Eagle Asset Management
St Petersburg,
Florida
| $1.17M | +$1.05M | +4 | New |
|
2
Renaissance Technologies
New York
| $274K | +$262K | +1 | New |
|
|
SONJCPFA
3
State of New Jersey Common Pension Fund A
Trenton,
New Jersey
| $205K | +$262K | +1 | New |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $119K | – | – | – |
|
|
SKK
5
Shepherd Kaplan Krochuk
Boston,
Massachusetts
| $99K | – | – | – |
|
6
Dimensional Fund Advisors
Austin,
Texas
| $98K | – | – | – |
|
7
Bank of America
Charlotte,
North Carolina
| $70K | – | – | – |
|
|
BIT
8
BlackRock Institutional Trust
San Francisco,
California
| $51K | – | – | – |
|
|
OC
9
Oppenheimer & Co
New York
| $41K | – | – | – |
|
10
Geode Capital Management
Boston,
Massachusetts
| $20K | – | – | – |
|
11
Northern Trust
Chicago,
Illinois
| $17K | – | – | – |
|
12
Citadel Advisors
Miami,
Florida
| $12K | – | – | – |
|
|
KCG
13
Knight Capital Group
| $6K | – | – | – |
|
ERNA Hedge Fund Activity: Q2 2013 in Review
3 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q2 2013, worth a combined $2.18M.
Buyers outnumbered sellers: 3 funds opened new ERNA positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
- 3 institutional investors held Eterna Therapeutics (ERNA) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $2.18M of Eterna Therapeutics stock for Q2 2013.
- 3 funds opened new Eterna Therapeutics positions in Q2 2013 and 0 closed out, a net change of +3 holders.
Based on aggregated 13F filings for Q2 2013.